Single User Software License GenASIs HiPath (IHC + CISH) for GenASIs Analysis & Review Platform added to exiting SpotScan Software includes Foot Pedal
HiPath Software for GenASIs Review & Analysis Platform (addition to SpotScan
GenASIs HiPath is a computer aided evaluation for immunohistochemistry and CISH assays that assists pathologists in reaching accurate, repeatable and standardized analysis. An easy to use tool that integrates with any standard microscope, GenASIs HiPath offers labs all the benefits of digital pathology without having to make a large upfront investment in WSI.
HER2 CISH assay is an FDA-approved alternative to HER2 fluorescent in situ hybridization (FISH). With a nearly 100% concordance rate with HER2 FISH, HER2 CISH allows pathologists to view tissue morphology and gene expression simultaneously by utilizing a bright-field microscope.
GenASIs HiPath captures fields of view defined by the pathologist, identifies and segments relevant cells, counts the spots in each cell and classifies each cell according to the spot count. In a fraction of a second, hundreds of cells are analyzed and classified along with statistical data for the current field of view and composite data for all of the fields of view captures.
Reports are generated at the click of a button containing images selected by the pathologist from those captured along with the statistical analysis and classification results.
FDA cleared for the following GenASIs applications: ALK, BandView, FISHView, UroVysion, CEP XY & HER2/neu FISH.
All other products and applications are intended for research use.
ASI develops image analysis & diagnostic tools for clinical and research applications. The company’s GenASIs platform integrates within the existing workflow of the microscope and LIS framework, improving upon the lab’s capabilities by providing a turn-key solution capable of slide capture, image analysis, case report and sign-out. With ASI, labs achieve higher throughput and enhanced clinical results based on accurate, reproducible and standardized analysis.
ASI specializes in cytogenetic and pathology applications, and currently supports brightfield and fluorescent microscopes for karyotype, in-situ hybridization (ISH) and immuno-histochemistry (IHC) applications. And with our unique capabilities in HyperSpectral imaging, ASI is also the leading supplier of spectral imaging microscopes to research labs around the globe.
Via an array of modular add-on tools which increase functionality and efficiency, ASI offers a custom-fit solution to any sized lab.
The GenASIs™ automated imaging platforms for genetic and pathology analysis provide state of the art diagnostic aids for pathologists and cytogeneticists, with reproducible and reliable results. The GenASIs platforms can be used with any brand of brightfield or fluorescent microscope, and support manual and automatic scanning for a wide range of workflows and applications, to best suit the needs, size and budget of any lab’s.
The GenASIs Hyperspectral is an innovative platform for companion diagnostics, providing the perfect solution for un-mixing of multiplexed biomarkers and superb qualitative and quantitative data by coping with many dyes simultaneously, both in brightfield and fluorescent staining.
The GenASIs platform is FDA cleared for FISH clinical applications such as ALK, UroVysion, HER2/neu, CEP XY and Karyotyping. ASI complies with major regulatory requirements and international quality standards.
ASI, the industry’s leading microscopy imaging solution provider since 1993, has dozens of registered patents in the US, Europe and Japan and thousands of systems deployed worldwide. ASI has worldwide offices in the US, Europe and Asia and a global network of distributors.
ASI Cytogenetics Booklet
ASI HyperSpectral Booklet
ASI HyperSpectral for Remote Sensing
ASI Pathology Booklet
CAP’14 Poster Presentation
Complete Pathology Solution